Characterising community pharmacist interventions to effectively reduce risk of cardiovascular disease onset

The Healthy Hearts in Pharmacy pilot trial significantly reduced primary CVD onset risk through community pharmacist management of multiple risk factors. This study aims to identify key clinical activities undertaken by pharmacists. Methods Seventy participants aged 50-74 years, taking antihypertensive or lipid-modifying medicines, and without diabetes or CVD, received a comprehensive baseline risk assessment followed by five pharmacist counselling sessions at monthly intervals, based on the Health Action Process Approach. GP involvement was promoted. Pharmacists documented key clinical activities after sessions. Anonymous questionnaires were mailed to all 12 treating pharmacists following the intervention.